Each week we highlight five things affecting the life sciences industry. Here's the latest. Positive outlook for CDMOs heading into 2025 Despite challenges in the biopharma contracting sector following the COVID-19 boom, 49% of contract development and manufacturing organizations remain ... READ MORE >